Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia
The authors would present the mid-term outcomes with the use of stent-supported angioplasty in the treatment of symptomatic chronic mesenteric ischemia (CMI). The present study is a retrospective analysis of 36 patients undergoing endovascular treatment of symptomatic CMI, between November 2000 and...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2011-07-01
|
| Series: | Surgical Techniques Development |
| Subjects: | |
| Online Access: | http://www.pagepress.org/journals/index.php/std/article/view/2468 |
| _version_ | 1797368318179409920 |
|---|---|
| author | Eva Schönefeld Susanne Szesny Konstantinos P. Donas Georgios A. Pitoulias Giovanni Torsello |
| author_facet | Eva Schönefeld Susanne Szesny Konstantinos P. Donas Georgios A. Pitoulias Giovanni Torsello |
| author_sort | Eva Schönefeld |
| collection | DOAJ |
| description | The authors would present the mid-term outcomes with the use of stent-supported angioplasty in the treatment of symptomatic chronic mesenteric ischemia (CMI). The present study is a retrospective analysis of 36 patients undergoing endovascular treatment of symptomatic CMI, between November 2000 and September 2009. Primary study endpoints were defined as primary patency, periprocedural and midterm mortality and complications, and symptom improvement after intervention. Forty-one mesenteric arteries (77.3% stenotic and 22.7% occluded vessels) were treated in 36 patients with 42 stents. In 30 patients (83.3%) one visceral artery and in 6 cases (16.7%) two visceral arteries were treated. Overall mortality was 16.7% (n=6) after a 60-month follow-up (mean follow-up period 30.1 months). Two early (<30-day) deaths were caused by visceral ischemia (n=2: 5.5%). Late death was procedure-related in one patient with re-occlusion of the superior mesenteric artery after 12 months. The other 3 patients died from non procedure-related causes; e.g. twice myocardial infarction. Initial symptom relief was observed in 29 patients (80.5%); 7 patients reported no change. Primary patency was 83.3% after 5 years and secondary patency was 90.5% (38 out of 42 stents) among all patients. Two conversions to open surgery were documented. First-line endovascular approach of CMI is a reasonable strategy. Close follow-up is mandatory due to symptom recurrence and restenosis. |
| first_indexed | 2024-03-08T17:30:41Z |
| format | Article |
| id | doaj.art-6bdd06d6e028414aae0fe9dc6f9de589 |
| institution | Directory Open Access Journal |
| issn | 2038-9574 2038-9582 |
| language | English |
| last_indexed | 2024-03-08T17:30:41Z |
| publishDate | 2011-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Surgical Techniques Development |
| spelling | doaj.art-6bdd06d6e028414aae0fe9dc6f9de5892024-01-02T15:20:36ZengMDPI AGSurgical Techniques Development2038-95742038-95822011-07-0111e2e210.4081/std.2011.e21580Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemiaEva Schönefeld0Susanne Szesny1Konstantinos P. Donas2Georgios A. Pitoulias3Giovanni Torsello4Centre of Vascular and Endovascular Surgery, University Hospital MünsterCentre of Vascular and Endovascular Surgery, University Hospital MünsterCentre of Vascular and Endovascular Surgery, University Hospital MünsterCentre of Vascular and Endovascular Surgery, University Hospital MünsterCentre of Vascular and Endovascular Surgery, University Hospital MünsterThe authors would present the mid-term outcomes with the use of stent-supported angioplasty in the treatment of symptomatic chronic mesenteric ischemia (CMI). The present study is a retrospective analysis of 36 patients undergoing endovascular treatment of symptomatic CMI, between November 2000 and September 2009. Primary study endpoints were defined as primary patency, periprocedural and midterm mortality and complications, and symptom improvement after intervention. Forty-one mesenteric arteries (77.3% stenotic and 22.7% occluded vessels) were treated in 36 patients with 42 stents. In 30 patients (83.3%) one visceral artery and in 6 cases (16.7%) two visceral arteries were treated. Overall mortality was 16.7% (n=6) after a 60-month follow-up (mean follow-up period 30.1 months). Two early (<30-day) deaths were caused by visceral ischemia (n=2: 5.5%). Late death was procedure-related in one patient with re-occlusion of the superior mesenteric artery after 12 months. The other 3 patients died from non procedure-related causes; e.g. twice myocardial infarction. Initial symptom relief was observed in 29 patients (80.5%); 7 patients reported no change. Primary patency was 83.3% after 5 years and secondary patency was 90.5% (38 out of 42 stents) among all patients. Two conversions to open surgery were documented. First-line endovascular approach of CMI is a reasonable strategy. Close follow-up is mandatory due to symptom recurrence and restenosis.http://www.pagepress.org/journals/index.php/std/article/view/2468chronic mesenteric ischemia, endovascular therapy, revascularization. |
| spellingShingle | Eva Schönefeld Susanne Szesny Konstantinos P. Donas Georgios A. Pitoulias Giovanni Torsello Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia Surgical Techniques Development chronic mesenteric ischemia, endovascular therapy, revascularization. |
| title | Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia |
| title_full | Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia |
| title_fullStr | Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia |
| title_full_unstemmed | Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia |
| title_short | Mid-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia |
| title_sort | mid term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia |
| topic | chronic mesenteric ischemia, endovascular therapy, revascularization. |
| url | http://www.pagepress.org/journals/index.php/std/article/view/2468 |
| work_keys_str_mv | AT evaschonefeld midtermoutcomesofendovasculartreatmentforsymptomaticchronicmesentericischemia AT susanneszesny midtermoutcomesofendovasculartreatmentforsymptomaticchronicmesentericischemia AT konstantinospdonas midtermoutcomesofendovasculartreatmentforsymptomaticchronicmesentericischemia AT georgiosapitoulias midtermoutcomesofendovasculartreatmentforsymptomaticchronicmesentericischemia AT giovannitorsello midtermoutcomesofendovasculartreatmentforsymptomaticchronicmesentericischemia |